Biosynth News and Resources

Biosynth has officially opened its expanded GMP bioconjugation facility in Berlin, further strengthening its global manufacturing network and CDMO services. The upgrade enhances production of conjugate vaccines and drugs, activated PEGs, and polymer-based excipients used in drug delivery. The expansion includes